OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-clinical tumor models of primary brain tumors: Challenges and opportunities
Farhana Akter, Brennan Simon, Nadine L. de Boer, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1875, Iss. 1, pp. 188458-188458
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity
Kok‐Siong Chen, Clemens Reinshagen, Thijs van Schaik, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 677
Open Access | Times Cited: 43

Tumor-Associated Macrophages in Gliomas—Basic Insights and Treatment Opportunities
Johannes K. Andersen, Hrvoje Miletić, Jubayer A. Hossain
Cancers (2022) Vol. 14, Iss. 5, pp. 1319-1319
Open Access | Times Cited: 64

Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Jiayi Zeng, Xiangxue Li, Max Sander, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 63

Engineered nanomaterials that exploit blood-brain barrier dysfunction for delivery to the brain
Jason R. Wu, Yazmin Hernandez, Katelyn Miyasaki, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114820-114820
Open Access | Times Cited: 39

Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment
Qi Cai, Xiaoqing Li, Hejian Xiong, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35

Contemporary Mouse Models in Glioma Research
William H. Hicks, Cylaina E. Bird, Jeffrey I. Traylor, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 712-712
Open Access | Times Cited: 41

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
Harpinder Kaur Brar, Jiney Jose, Zimei Wu, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 31

Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
Hasan Slika, Ziya Karimov, Paolo Alimonti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16316-16316
Open Access | Times Cited: 19

Pre-clinical models for evaluating glioma targeted immunotherapies
Stephen C. Frederico, Xiaoran Zhang, Baoli Hu, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14

Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice
Longsha Liu, Thijs van Schaik, Kok‐Siong Chen, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 5

Isoorientin: Unveiling the hidden flavonoid's promise in combating cancer development and progression – A comprehensive review
Lucas Fornari Laurindo, Karina Torres Pomini, Enzo Pereira de Lima, et al.
Life Sciences (2024), pp. 123280-123280
Open Access | Times Cited: 5

Advances in 3D culture systems for therapeutic discovery and development in brain cancer
Janith Wanigasekara, Patrick J. Cullen, Paula Bourke, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103426-103426
Closed Access | Times Cited: 20

Opportunities in the translational pipeline for pediatric brain cancer therapies
L. Rivera, Nora L. Springer, Katherine Bailey, et al.
Pediatric Research (2025)
Open Access

Advances in Tracing Techniques: Mapping the Trajectory of Mesenchymal Stem-Cell-Derived Extracellular Vesicles
Jingqi Li, Zhaoyu Wang, Yongchun Wei, et al.
Chemical & Biomedical Imaging (2025) Vol. 3, Iss. 3, pp. 137-168
Open Access

Fluorescence-Guided Resection of GL261 Red-FLuc and TRP-mCherry-FLuc Mouse Glioblastoma Tumors
Louis Rodgers, Bryan Maloney, Anika M. S. Hartz, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 734-734
Open Access

An improved F98 glioblastoma rat model to evaluate novel treatment strategies incorporating the standard of care
Velislava Zoteva, Valerie De Meulenaere, Marthe De Boeck, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296360-e0296360
Open Access | Times Cited: 3

Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma
Virginia Aragon‐Sanabria, Anusha Aditya, Li Zhang, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 13, pp. 2938-2952
Open Access | Times Cited: 15

Pioneering models of pediatric brain tumors
Florina Grigore, Serena Johanna Yang, Clark C. Chen, et al.
Neoplasia (2023) Vol. 36, pp. 100859-100859
Open Access | Times Cited: 8

Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models
Francesco Antonica, Giuseppe Aiello, Alessia Soldano, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 13

Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
Kallen Schwark, Dana Messinger, Jessica Cummings, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13

A rigorous behavioral testing platform for the assessment of radiation-induced neurological outcomes
Olivia G.G. Drayson, Marie‐Catherine Vozenin, Charles L. Limoli
Methods in cell biology (2023), pp. 177-197
Closed Access | Times Cited: 7

Human Organoid Tumor Transplantation Identifies Functional Glioblastoma - Microenvironmental Communication Mediated by PTPRZ1
Weihong Ge, Ryan L. Kan, Can Yilgor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2

Co-doped ZnO nanowires: Synthesis, photocatalytic performance, and cytotoxic activity against human brain glioblastoma cells
Khadijeh Hamidian, Mina Sarani, Ahmad Najafidoust, et al.
Results in Chemistry (2022) Vol. 5, pp. 100734-100734
Open Access | Times Cited: 11

Adult brain tumour research in 2024: Status, challenges and recommendations
Karin Purshouse, Helen Bulbeck, Alasdair G Rooney, et al.
Neuropathology and Applied Neurobiology (2024) Vol. 50, Iss. 2
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top